PHARMALINE

IMPOROVES QUALITY OF LIFE

Home   |   Health   |   Malia Group   |   Sitemap   |   Privacy
Home » News » Pharmaline Launches New Cholesterol-Lowering Drug Print    |    Email to a Friend    |    -    +
Pharmaline Launches New Cholesterol-Lowering Drug


Pharmaline has recently launched Rosucor, the company’s latest generation of lipid-lowering drugs. Belonging to the class of HMG-CoA inhibitors (statins), Rosucor is indicated to control the level of cholesterol and triglycerides in the blood and to prevent cardiovascular diseases in specific risk dependent patients. Rosucor is available in 10mg, 20mg and 40mg tablets; 30 tablets per box.


For more composition information and data sheet, please click here.